<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10069412" created="28/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10069412</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="anti-rheumatic_compound" sem="Organic_compound_other">Anti-rheumatic compound</term> <term id="T2" lex="aurothioglucose" sem="Organic_compound_other">aurothioglucose</term> inhibits <term id="T3" lex="tumor_necrosis_factor-alpha-induced_HIV-1_replication" sem="Other"><term id="T4" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule">tumor necrosis factor-alpha</term>-induced <term id="A1" sem="Virus">HIV-1</term> replication</term> in latently infected <cons id="T5" lex="(AND OM10.1_cell Ach2_cell)" sem="(AND Cell_cultured Cell_cultured)"><frag id="F1"><term id="A52" sem="Cell_cultured">OM10.1</term></frag> and <frag id="F2"><term id="A53" sem="Cell_cultured">Ach2</term></frag> <frag id="F3"><term id="A54" sem="Cell_cultured">cells</term></frag></cons>.</sentence>
<event KT="Other" id="E1">
<type class="Viral_life_cycle"/>
<theme idref="A1"/>
<clue>Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 <clueType>replication</clueType> in latently infected OM10.1 and Ach2 cells.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue>Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-<clueType>induced</clueType> HIV-1 replication in latently infected OM10.1 and Ach2 cells.</clue>
</event>
<event id="E3">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T2"/>
<clue>Anti-rheumatic compound aurothioglucose <clueType>inhibits</clueType> tumor necrosis factor-alpha-induced HIV-1 replication <clueLoc>in latently infected OM10.1</clueLoc> and Ach2 <clueLoc>cells</clueLoc>.</clue>
</event>
<event id="E103">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T2"/>
<clue>Anti-rheumatic compound aurothioglucose <clueType>inhibits</clueType> tumor necrosis factor-alpha-induced HIV-1 replication <clueLoc>in latently infected</clueLoc> OM10.1 and <clueLoc>Ach2 cells</clueLoc>.</clue>
</event>
<event id="E203">
<type class="Initiation_of_viral_infection"/>
<theme idref="A1"/>
<theme idref="A52" idref1="A54"/>
<clue>Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in <clueType>latently infected</clueType> OM10.1 and Ach2 cells.</clue>
<comment>NO COREFTHEME for A1</comment></event>
<event id="E303">
<type class="Initiation_of_viral_infection"/>
<theme idref="A1"/>
<theme idref="A53" idref1="A54"/>
<clue>Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in <clueType>latently infected</clueType> OM10.1 and Ach2 cells.</clue>
<comment>NO COREFTHEME for A1</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> is a potent cellular activator of <term id="A3" sem="DNA_domain_or_region"><term id="A2" sem="Virus">HIV-1</term> gene</term> expression.</sentence>
<event KT="Other" id="E4">
<type class="Gene_expression"/>
<theme idref="A3"/>
<clue>NF-kappaB is a potent cellular activator of HIV-1 gene <clueType>expression</clueType>.</clue>
</event>
<event KT="Fact" Manner="High" id="E5" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T6"/>
<clue>NF-kappaB is a <clueManner>potent</clueManner> cellular <clueType>activator</clueType> <linkTheme>of</linkTheme> HIV-1 gene expression.</clue>
</event>
<sentence id="S3">Down-regulation of <term id="T7" lex="NF-kappaB_activation" sem="Other"><term id="T8" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> is known to inhibit <term id="T9" lex="HIV_replication" sem="Other"><term id="A4" sem="Virus">HIV</term> replication</term> from the <term id="T10" lex="latently_infected_cell" sem="Cell_natural">latently infected cells</term>.</sentence>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<clue>Down-regulation of NF-kappaB <clueType>activation</clueType> is known to inhibit HIV replication from the latently infected cells.</clue>
</event>
<event KT="Other" id="E7">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<clue><clueType>Down-regulation</clueType> <linkTheme>of</linkTheme> NF-kappaB activation is known to inhibit HIV replication from the latently infected cells.</clue>
</event>
<event KT="Other" id="E8">
<type class="Viral_life_cycle"/>
<theme idref="A4"/>
<clue>Down-regulation of NF-kappaB activation is known to inhibit HIV <clueType>replication</clueType> from the latently infected cells.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="E7"/>
<clue>Down-regulation of NF-kappaB activation is <clueKT>known</clueKT> to <clueType>inhibit</clueType> HIV replication <clueLoc>from the latently infected cells</clueLoc>.</clue>
</event>
<sentence id="S4"><term id="T11" lex="gold_compound" sem="Element">Gold compounds</term> have been effectively used for many decades in the treatment of <term id="T12" lex="rheumatoid_arthritis" sem="Other">rheumatoid arthritis</term>.</sentence>
<sentence id="S5">We previously reported that <term id="T13" lex="gold_compound" sem="Element">gold compounds</term>, especially <term id="T14" lex="aurothioglucose" sem="Organic_compound_other">aurothioglucose</term> (<term id="T15" lex="AuTG" sem="Element">AuTG</term>) containing monovalent <term id="T16" lex="gold_ion" sem="Element">gold ion</term>, inhibited the <term id="A5" sem="DNA_domain_or_region">DNA</term>-binding of <term id="T17" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in vitro.</sentence>
<event KT="Other" id="E10">
<type class="Binding"/>
<theme idref="A5"/>
<theme idref="T17"/>
<clue>We previously reported that gold compounds, especially aurothioglucose (AuTG) containing monovalent gold ion, inhibited the DNA-<clueType>binding</clueType> <linkTheme>of</linkTheme> NF-kappaB in vitro.</clue>
</event>
<event KT="Analysis" Source="Other" id="E11">
<type class="Negative_regulation"/>
<theme idref="E10"/>
<cause idref="T15"/>
<clue>We <clueSource>previously</clueSource> <clueKT>reported</clueKT> that <corefCause>gold compounds</corefCause>, especially aurothioglucose (AuTG) containing monovalent gold ion, <clueType>inhibited</clueType> the DNA-binding of NF-kappaB in vitro.</clue>
</event>
<sentence id="S6">In this report we have examined the efficacy of the <term id="T18" lex="gold_compound" sem="Inorganic_compound">gold compound</term> <term id="T19" lex="AuTG" sem="Inorganic_compound">AuTG</term> as an inhibitor of <term id="T20" lex="HIV_replication" sem="Other"><term id="A6" sem="Virus">HIV</term> replication</term> in latently infected <cons id="T21" lex="(AND OM10.1_cell _Ach2_cell)" sem="(AND Cell_cultured Cell_cultured)"><frag id="F4"><term id="A152" sem="Cell_cultured">OM10.1</term></frag> and <frag id="F5"><term id="A153" sem="Cell_cultured">Ach2</term></frag> <frag id="F6"><term id="A154" sem="Cell_cultured">cells</term></frag></cons>.</sentence>
<event KT="Other" id="E12">
<type class="Viral_life_cycle"/>
<theme idref="A6"/>
<clue>In this report we have examined the efficacy of the gold compound AuTG as an inhibitor of HIV <clueType>replication</clueType> in latently infected OM10.1 and Ach2 cells.</clue>
</event>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T19"/>
<clue>In this report we have <clueKT>examined</clueKT> the efficacy of the gold compound AuTG as an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> HIV replication <clueLoc>in latently infected OM10.1</clueLoc> and Ach2 cells.</clue>
</event>
<event KT="Investigation" id="E113" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T19"/>
<clue>In this report we have <clueKT>examined</clueKT> the efficacy of the gold compound AuTG as an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> HIV replication <clueLoc>in latently infected</clueLoc> OM10.1 and <clueLoc>Ach2 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E213">
<type class="Initiation_of_viral_infection"/>
<theme idref="A6"/>
<theme idref="A152" idref1="A154"/>
<clue>In this report we have examined the efficacy of the gold compound AuTG as an inhibitor of HIV replication in <clueType>latently infected</clueType> OM10.1 and Ach2 cells.</clue>
</event>
<event KT="Other" id="E313">
<type class="Initiation_of_viral_infection"/>
<theme idref="A6"/>
<theme idref="A153" idref1="A154"/>
<clue>In this report we have examined the efficacy of the gold compound AuTG as an inhibitor of HIV replication in <clueType>latently infected</clueType> OM10.1 and Ach2 cells.</clue>
</event>
<sentence id="S7"><term id="T22" lex="tumor_necrosis_factor_(TNF)-alpha-induced_HIV-1_replication" sem="Other"><term id="T23" lex="Tumor_necrosis_factor_(TNF)-alpha" sem="Protein_molecule">Tumor necrosis factor (TNF)-alpha</term>-induced <term id="A7" sem="Virus">HIV-1</term> replication</term> in <term id="T24" lex="OM10.1_cell" sem="Cell_cultured">OM10.1</term> or <term id="T25" lex="Ach2_cell" sem="Cell_cultured">Ach2 cells</term> was significantly inhibited by non-cytotoxic doses of <term id="T26" lex="AuTG" sem="Inorganic_compound">AuTG</term> (&gt;10 microM in <term id="T27" lex="OM10.1_cell" sem="Inorganic_compound">OM10.1 cells</term> and &gt;25 F.M in <term id="T28" lex="Ach2_cell" sem="Cell_cultured">Ach2 cells</term>), while 25 microM of the <term id="T29" lex="counter-anion_thioglucose" sem="Protein_molecule">counter-anion thioglucose</term> (<term id="T30" lex="TG" sem="Protein_molecule">TG</term>) or <term id="T31" lex="gold_compound" sem="Inorganic_compound">gold compound</term> containing <term id="T32" lex="divalent_gold_ion" sem="Element">divalent <term id="T33" lex="gold_ion" sem="Element">gold ion</term></term>, <term id="T34" lex="HAuCl3" sem="Inorganic_compound">HAuCl3</term>, had no effect.</sentence>
<event KT="Other" id="E14">
<type class="Viral_life_cycle"/>
<theme idref="A7"/>
<clue>Tumor necrosis factor (TNF)-alpha-induced HIV-1 <clueType>replication</clueType> in OM10.1 or Ach2 cells was significantly inhibited by non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, had no effect.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T23"/>
<clue>Tumor necrosis factor (TNF)-alpha-<clueType>induced</clueType> HIV-1 replication <clueLoc>in OM10.1</clueLoc> or Ach2 <clueLoc>cells</clueLoc> was significantly inhibited by non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, had no effect.</clue>
</event>
<event KT="Other" id="E115">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T23"/>
<clue>Tumor necrosis factor (TNF)-alpha-<clueType>induced</clueType> HIV-1 replication <clueLoc>in</clueLoc> OM10.1 or <clueLoc>Ach2 cells</clueLoc> was significantly inhibited by non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, had no effect.</clue>
</event>
<event Manner="High" id="E16">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T26"/>
<clue>Tumor necrosis factor (TNF)-alpha-induced HIV-1 replication in OM10.1 or Ach2 cells was <clueManner>significantly</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, had no effect.</clue>
</event>
<event Manner="High" id="E116">
<type class="Negative_regulation"/>
<theme idref="E115"/>
<cause idref="T26"/>
<clue>Tumor necrosis factor (TNF)-alpha-induced HIV-1 replication in OM10.1 or Ach2 cells was <clueManner>significantly</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, had no effect.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E17">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="T30"/>
<clue>Tumor necrosis factor (TNF)-alpha-induced HIV-1 replication in OM10.1 or Ach2 cells was significantly inhibited by non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, <clueType>had</clueType> <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>No corefTheme</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E117">
<type class="Regulation"/>
<theme idref="E115"/>
<cause idref="T30"/>
<clue>Tumor necrosis factor (TNF)-alpha-induced HIV-1 replication in OM10.1 or Ach2 cells was significantly inhibited by non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, <clueType>had</clueType> <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>No corefTheme</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E18">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="T34"/>
<clue>Tumor necrosis factor (TNF)-alpha-induced HIV-1 replication in OM10.1 or Ach2 cells was significantly inhibited by non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, <clueType>had</clueType> <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>No corefTheme</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E118">
<type class="Regulation"/>
<theme idref="E115"/>
<cause idref="T34"/>
<clue>Tumor necrosis factor (TNF)-alpha-induced HIV-1 replication in OM10.1 or Ach2 cells was significantly inhibited by non-cytotoxic doses of AuTG (&gt;10 microM in OM10.1 cells and &gt;25 F.M in Ach2 cells), while 25 microM of the counter-anion thioglucose (TG) or gold compound containing divalent gold ion, HAuCl3, <clueType>had</clueType> <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>No corefTheme</comment></event>
<sentence id="S8">The effect of <term id="T35" lex="AuTG" sem="Element"><term id="T36" lex="AuTG" sem="Inorganic_compound">AuTG</term></term> on <term id="T37" lex="NF-kappaB-dependent_gene_expression" sem="Other"><term id="T38" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>-dependent <term id="A9" sem="Other">gene expression</term></term> was confirmed by a <term id="T39" lex="transient_CAT_assay" sem="Other">transient <term id="T40" lex="CAT" sem="Protein_molecule">CAT</term> assay</term>.</sentence>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="A9"/>
<cause idref="T38"/>
<clue>The effect of AuTG on NF-kappaB-<clueType>dependent</clueType> gene expression was confirmed by a transient CAT assay.</clue>
</event>
<event KT="Analysis" id="E21">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="T35"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> AuTG <linkTheme>on</linkTheme> NF-kappaB-dependent gene expression was <clueKT>confirmed</clueKT> <clueExperiment>by a transient CAT assay</clueExperiment>.</clue>
</event>
<sentence id="S9">Specific staining as well as <term id="T41" lex="electron_microscopic_examination" sem="Other">electron microscopic examinations</term> revealed the accumulation of <term id="T42" lex="metal_gold" sem="Element">metal gold</term> in the cells, supporting our previous hypothesis that <term id="T43" lex="gold_ion" sem="Element">gold ions</term> could block <term id="T44" lex="NF-kappaB-DNA_binding" sem="Other"><term id="T45" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>-<term id="A10" sem="DNA_domain_or_region">DNA</term> binding</term> by a <term id="T46" lex="redox_mechanism" sem="Other">redox mechanism</term>.</sentence>
<event KT="Analysis" id="E22">
<type class="Localization"/>
<theme idref="T42"/>
<clue>Specific staining as well as electron microscopic examinations <clueKT>revealed</clueKT> the <clueType>accumulation</clueType> <linkTheme>of</linkTheme> metal gold <clueLoc>in the cells</clueLoc>, supporting our previous hypothesis that gold ions could block NF-kappaB-DNA binding by a redox mechanism.</clue>
</event>
<event KT="Other" id="E23">
<type class="Binding"/>
<theme idref="T45"/>
<theme idref="A10"/>
<clue>Specific staining as well as electron microscopic examinations revealed the accumulation of metal gold in the cells, supporting our previous hypothesis that gold ions could block NF-kappaB-DNA <clueType>binding</clueType> by a redox mechanism.</clue>
</event>
<event CL="L1" KT="Analysis" Source="Other" id="E24">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T43"/>
<clue>Specific staining as well as electron microscopic examinations revealed the accumulation of metal gold in the cells, supporting our <clueSource>previous</clueSource> <clueKT>hypothesis</clueKT> that gold ions <clueCL>could</clueCL> <clueType>block</clueType> NF-kappaB-DNA binding by a redox mechanism.</clue>
</event>
<event KT="Other" id="E50">
<type class="Correlation"/>
<theme idref="T46"/>
<theme idref="E24"/>
<clue><clueExperiment>Specific staining</clueExperiment> as well as <clueExperiment>electron microscopic examinations</clueExperiment> revealed the accumulation of metal gold in the cells, supporting our previous hypothesis that gold ions could block NF-kappaB-DNA binding <clueType>by</clueType> a redox mechanism.</clue>
</event>
<sentence id="S10">These observations indicate that the monovalent <term id="T47" lex="gold_compound" sem="Inorganic_compound">gold compound</term> <term id="T48" lex="AuTG" sem="Inorganic_compound"><term id="T49" lex="AuTG" sem="Element">AuTG</term></term> is a potentially useful drug for the treatment of <term id="T50" lex="patient" sem="Multicellular_organism_natural">patients</term> infected with <term id="T51" lex="HIV" sem="Virus">HIV</term>.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
